top of page

Board of Directors

Julie M. Cherrington, PhD

Board Chair

Venture Partner at Brandon Capital

Benjamin P. Chen, PhD

Director

Partner at Panacea Venture

Ron Mazumder, PhD

Director

Partner at Illumina Ventures

Stefan Pflanz, PhD

Director

Executive Director at Boehringer Ingelheim Venture Fund USA

Tom Smart

Director

CEO, Actym Therapeutics

BI_Logo.jpg
Fichier-1-1.png
illumina9.21.21A_0.jpg
63ad390755e11ac85554290c_korean investment_3x.png
Jlo-Ventures-wide-75.jpg
GKCC-3.jpg

Investors

Our Team

We are united in our mission to develop new immuno-oncology drugs for patients with solid tumors, and the families who support them.

tom smart headshot.jpg

Tom Smart

Chief Executive Officer

mar j headshot.jpg

Mary J. Janatpour

Chief Scientific Officer

SteveV5292.jpg

Steve Vicik, PhD

Chief Technical Officer

Deep Headshot.jpg

Shouryadeep “Deep” Srivastava, MD, PhD

Senior Vice President of Clinical Development

actym footer final.jpg
bottom of page